NSE
GENUSPAPER
BSE
538961
ISIN
INE949P01018

GENUS P&B

Forest Materials· Paper Forest & Jute Products· Paper & Paper Products

₹10.47

+₹0.04 (+0.38%)

NSE close ·

GENUS P&B closed at ₹10.47 on 9 Nov 2026, up 0.38% on the day, and is down 31.30% over the past year.

52-week range35.5% below high
₹8.67₹16.23
TodayVolume 36,371
₹10.36₹10.89

Price history

Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹8.88 to ₹15.69.

Price returns, excl. dividends. 3Y, 5Y and Max are annualised.

Fundamentals

Market cap
₹269 Cr

Market cap at the 9 Nov 2026 close.

Quarterly results

GENUS P&B quarterly results
QuarterRevenueNet profitYoY profitEPS
Jun 2026₹219 Cr₹3.52 Cr—₹0.14

Armor risk check

GENUS P&B moves about 3× as much as the market

Volatility, past year

GENUS P&B43%
Nifty 50015%

Worst fall, past year

GENUS P&B−43%
Nifty 500−15%

Compared with the Nifty 500 over the past 12 months.

Check it against your portfolio in the app

FAQs

What is GENUS P&B's share price today?

GENUS P&B (NSE: GENUSPAPER) closed at ₹10.47 on 9 Nov 2026, up 0.38% from the previous close of ₹10.43. It traded between ₹10.36 and ₹10.89 that day.

What are GENUS P&B's 52-week high and low?

Over the last 52 weeks GENUS P&B traded between ₹8.67 and ₹16.23, adjusted for splits and bonuses.

What are GENUS P&B's NSE symbol, BSE code and ISIN?

GENUS P&B has NSE symbol GENUSPAPER, BSE code 538961, ISIN INE949P01018.

How has GENUS P&B performed over 1, 3 and 5 years?

GENUS P&B's share price return: 1Y −31.30%, 3Y −20.96% a year, 5Y −0.89% a year. Dividends are not included.

What is GENUS P&B's market cap?

GENUS P&B's market cap is ₹269 Cr at the close on 9 Nov 2026.

Which sector is GENUS P&B in?

GENUS P&B is in NSE's Forest Materials sector, in the Paper Forest & Jute Products industry (Paper & Paper Products).

For information only. Not investment advice or a research report. Past performance does not guarantee future returns.

Full disclaimer

See how GENUS P&B fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app